Temam Stephane, Casiraghi Odile, Lahaye Jean-Baptiste, Bosq Jacques, Zhou Xian, Julieron Morbize, Mamelle Gerard, Lee J Jack, Mao Li, Luboinski Bernard, Benard Jean, Janot Francois
Department of Head and Neck Surgery, Villejuif, France.
Clin Cancer Res. 2004 Jun 15;10(12 Pt 1):4022-8. doi: 10.1158/1078-0432.CCR-04-0199.
Postoperative radiotherapy is used to prevent local recurrence of head and neck squamous cell carcinoma in patients with positive surgical margins. We sought to determine whether tetranucleotide microsatellite instability could be detected in surgical margins and used to predict local recurrence.
We prospectively collected tumor and surgical margin specimens from patients with head and neck squamous cell carcinoma who had undergone surgical resection at Institut Gustave-Roussy during a 1-year period. Margins were considered positive if extensive pathological examination revealed either carcinoma within 5 mm or dysplasia. We tested five tetranucleotide microsatellite markers (UT5085, L17686, D9S753, ACTBP2, and CSF1R) in the tumor specimens and paired surgical margins of the patients whose margins were negative on pathological examination.
Pathological examination revealed that among the 76 patients, 22 had positive margins; therefore, these patients were excluded. Of the 54 remaining patients, 26 (48%) had tumors informative for markers UT5085, L17686, or both; the other 3 markers were not informative. Seven (27%) of the 26 informative tumors had the same instability pattern in the surgical margins. At a median follow-up of 26 months, 5 of the 7 local recurrences occurred in patients with molecularly positive surgical margins. A strong, independent association was found between positive surgical margins and local recurrence (P = 0.01; hazard ratio, 6.49).
Tetranucleotide microsatellite instability in surgical margins may be a useful biomarker to predict local recurrence of head and neck squamous cell carcinoma in patients with apparently disease-free margins.
术后放疗用于预防手术切缘阳性的头颈部鳞状细胞癌患者的局部复发。我们试图确定是否能在手术切缘检测到四核苷酸微卫星不稳定性,并用于预测局部复发。
我们前瞻性地收集了在古斯塔夫 - 鲁西研究所接受手术切除的头颈部鳞状细胞癌患者的肿瘤和手术切缘标本,为期1年。如果广泛的病理检查显示5mm内有癌或发育异常,则切缘被视为阳性。我们在病理检查切缘为阴性的患者的肿瘤标本和配对手术切缘中检测了五个四核苷酸微卫星标记(UT5085、L17686、D9S753、ACTBP2和CSF1R)。
病理检查显示,76例患者中,22例切缘阳性;因此,这些患者被排除。在其余54例患者中,26例(48%)肿瘤对标记UT5085、L17686或两者有信息;其他3个标记无信息。26例有信息的肿瘤中有7例(27%)在手术切缘具有相同的不稳定性模式。中位随访26个月时,7例局部复发中有5例发生在分子切缘阳性的患者中。手术切缘阳性与局部复发之间存在强烈的独立关联(P = 0.01;风险比,6.49)。
手术切缘中的四核苷酸微卫星不稳定性可能是预测切缘看似无病的头颈部鳞状细胞癌患者局部复发的有用生物标志物。